Magnetic Resonance Imaging
Volume 30, Issue 2 , Pages 165-170 , February 2012

The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience

  • Yunbin Chen

      Affiliations

    • Department of Radiology, Fujian Medical University Teaching Hospital, Fujian Provincial Cancer Hospital, 350014, Fujian, P.R. China
    • Corresponding Author InformationCorresponding author. Tel.: +86 13950301116; fax: +86 591 83638732.
    • ,
  • Jing Zhong

      Affiliations

    • Department of Radiology, Fujian Medical University Teaching Hospital, Fujian Provincial Cancer Hospital, 350014, Fujian, P.R. China
    • ,
  • Hui Wu

      Affiliations

    • Department of Medical Oncology in Lymphoma, Fujian Medical University Teaching Hospital, Fujian Provincial Cancer Hospital, 350014, Fujian, P.R. China
    • ,
  • Ningbin Chen

      Affiliations

    • Department of Medical Oncology in Lymphoma, Fujian Medical University Teaching Hospital, Fujian Provincial Cancer Hospital, 350014, Fujian, P.R. China

Received 11 May 2011 ,Revised 18 July 2011 ,Accepted 18 September 2011.

References 

  1. Zinzani PL. Lymphoma: diagnosis, staging, natural history, and treatment strategies. Semin Oncol. 2005;32:S4–S10
  2. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol. 2006;79:633–635
  3. Even-Sapir E, Israel O. Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl 1):S65–S81
  4. Juweid ME, Wiseman GA, Vose JM, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol. 2005;23:4652–4661
  5. Mikhaeel NG, Hutchings M, Fields PA, et al. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol. 2005;16:1514–1523
  6. Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging. 2006;33:22–28
  7. Rajendran JG, Wilson DC, Conrad EU. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging. 2003;30:695–704
  8. Spaepen K, Stroobants S, Dupont P. [(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?. Eur J Nucl Med Mol Imaging. 2003;30:682–688
  9. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. J Radiat Med. 2004;22(4):275–282
  10. Komori T, Narabayashi I, Matsumura K, et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. J Ann Nucl Med. 2007;21:209–215
  11. Antoun H, Popa L, Momo JA, et al. Whole body diffusion weighted MRI compared to 18F-FDG position emission tomography for the detection and localization of malignant lesions. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada. 2008;[Abstract 2715]
  12. Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images. J Megn Reson Med Sci. 2007;6(3):147–155
  13. Ohno Y, Koyama H, Nogami M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging. 2007;26:498–509
  14. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment — utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. J Radiol. 2008;248:643–654
  15. Cui Y, Zhang XP, Sun YS, et al. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. J Radiol. 2008;248(3):894–900
  16. Reichardt W, Juettner E, Uhl M, et al. Diffusion-weighted imaging as predictor of therapy response in an animal model of Ewing sarcoma. J Invest Radiol. 2009;44(5):298–303
  17. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. J Radiol. 2004;232(3):685–692
  18. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. J Clin Cancer Res. 2009;15(3):986–994
  19. Theilmann RJ, Borders R, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. J Neoplasia. 2004;6(6):831–837
  20. Li S, Xue HD, Wang XH, et al. MR diffusion weighted imaging for evaluation of radiotherapeutic effects on rabbit VX2 tumor model. J Chin Med Sci. 2008;23(3):172–177
  21. Huang MQ, Pickup S, Nelson DS, et al. Monitoring response to chemotherapy of non-Hodgkin's lymphoma xenografts by T2-weighted and diffusion-weighted MRI. NMR Biomed. 2008;21:1021–1029
  22. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guideline. J Clin Oncol. 1984;2:187–193
  23. Li S, Sun F, Jin ZY, et al. Whole-body diffusion-weighted imaging: technical improvement and preliminary results. J Magn Reson Imaging. 2007;26:1139–1144
  24. Stephen BE, David RB, Carolyn CC, et al. AJCC cancer staging handbook. In: American Joint Committee on Cancer. 7th ed.. 2010;p. 671
  25. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216
  26. Ballon D, Watts R, Dyke JP, et al. Imaging therapeutic response in human bone marrow using rapid whole-body MRI. J Magn Reson Med. 2004;52(6):1234–1238

PII: S0730-725X(11)00351-1

doi: 10.1016/j.mri.2011.09.019

Magnetic Resonance Imaging
Volume 30, Issue 2 , Pages 165-170 , February 2012

Article Tools

* Image Usage & Resolution